Invites Biocore Co., Ltd. (XKON:A216400) agreed to acquire 85% stake in PROCAGEN from Byun Seok-soo for approximately KRW 12,748 million on July 14, 2022. PROCAGEN generated Total assets of KRW 1,101 million, Total equity of KRW 993 million and Net Income of KRW -528 million for the financial year 2021. Transaction is expected to close on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,790 KRW | +0.46% | -6.89% | -5.48% |
1st Jan change | Capi. | |
---|---|---|
-5.48% | 49.62M | |
-27.70% | 9.87B | |
+27.06% | 2.89B | |
-16.78% | 2.75B | |
-15.31% | 2.13B | |
-21.41% | 1.65B | |
+68.70% | 1.47B | |
+29.75% | 811M | |
-5.02% | 733M | |
-29.39% | 510M |
- Stock Market
- Equities
- A216400 Stock
- News Invites Biocore Co., Ltd.
- Invites Biocore Co., Ltd. agreed to acquire 85% stake in PROCAGEN from Byun Seok-soo.